BMS-200150

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameBMS-200150
Drug Alias NameBMS-200150
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMicrosomal triglyceride transfer protein inhibitors
TargetsMicrosomal triglyceride transfer protein
Therapy Area/IndicationsHyperlipidemiasAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBristol-Myers Squibb Company
Active IndicationsN/A
Inactive IndicationsHyperlipidemiasAtherosclerosis

Other Information

ATC CodeN/A
Related LinksN/A